secwatch.observer — SEC 8-K summary
======================================

Issuer:     Personalis, Inc. (PSNL)
CIK:        0001527753
Form:       8-K
Filed at:   2026-07-20T13:18:31+00:00
Accession:  0001193125-26-308488
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempus to acquire Personalis for $16.25/share, $1.5B enterprise value
---------------------------------------------------------------------

- Consideration of $16.25 per share, 6% premium to last close, 28% premium to 30-day VWAP.
- Total enterprise value of $1.5B net of Tempus' existing ownership; 100% stock with cash option up to 50%.
- Closing expected late 2026 or early 2027; subject to Personalis shareholder and regulatory approvals.
- Personalis reports preliminary Q2 revenue of $22.4M and 10,384 clinical tests, up 33% QoQ.
- Acquisition combines Personalis' MRD technology with Tempus' AI platform; MRD market opportunity $20B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527753/000119312526308488/0001193125-26-308488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527753/000119312526308488/d68794d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-308488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer